CYP1B1-AS1: Key Regulator of Cell Cycle and Many Signaling Pathways

Target Name: CYP1B1-AS1

NCBI ID: G285154

CYP1B1-AS1

Other Name(s): C2orf58 | CYP1B1 antisense RNA 1

CYP1B1-AS1: Key Regulator of Cell Cycle and Many Signaling Pathways

CYP1B1-AS1, also known as C2orf58, is a protein that is expressed in various tissues throughout the body. It is a key regulator of the cell cycle, which is the process by which cells grow, divide, and replicate their genetic material. CYP1B1-AS1 plays a crucial role in controlling the length of the cell cycle, and it is often used as a drug target or biomarker.

CYP1B1-AS1 is a member of the T-cell kinase family, which is responsible for regulating many cellular processes, including the cell cycle, cell adhesion, and signaling pathways. The T-cell kinase family is a large family of proteins that are involved in the regulation of cell growth, differentiation, and death. CYP1B1-AS1 is one of the best-studied members of this family, and it is known to play a key role in the regulation of the cell cycle.

CYP1B1-AS1 is expressed in many different tissues throughout the body, including the brain, heart, liver, and muscle. It is often used as a biomarker to monitor the effectiveness of cancer treatments, as well as to diagnose diseases such as neurodegenerative disorders. CYP1B1-AS1 levels can also be used to predict the risk of certain diseases, such as breast cancer.

CYP1B1-AS1 is involved in many different cellular processes, including the regulation of the cell cycle, cell adhesion, and signaling pathways. It is a key regulator of the G1 phase of the cell cycle, which is the phase when the cell prepares for cell division. During the G1 phase, CYP1B1-AS1 helps to ensure that the cell has enough copies of its genetic material to divide. It also plays a role in the regulation of the G2 phase of the cell cycle, which is the phase when the cell prepares for cell division again.

CYP1B1-AS1 is also involved in the regulation of cell adhesion. Cells are attached to the surrounding tissue through a process called adhesion, and CYP1B1-AS1 plays a role in ensuring that cells stick together and form tissues. It is also involved in the regulation of the migration of cells, which is the process by which cells move from one location to another in the body.

In addition to its role in the cell cycle and cell adhesion, CYP1B1-AS1 is also involved in many signaling pathways. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in many cellular processes, including cell growth, differentiation, and survival. CYP1B1-AS1 also plays a role in the regulation of the T-cell receptor signaling pathway, which is involved in the development and function of T-cells.

CYP1B1-AS1 is a potential drug target for many different diseases. Because it plays a role in the regulation of the cell cycle, it is often used as a target for drugs that are designed to inhibit cell division. CYP1B1-AS1 is also a good candidate for targeting drugs that affect the PI3K/Akt signaling pathway, as this pathway is often involved in many cellular processes that are affected by these drugs.

In addition to its potential as a drug target, CYP1B1-AS1 is also a useful biomarker for many different diseases. Its levels can be used to monitor the effectiveness of cancer treatments, as well as to diagnose diseases such as neurodegenerative disorders. CYP1B1-AS1 levels can also be used to predict the risk of certain diseases, such as breast cancer.

Protein Name: CYP1B1 Antisense RNA 1

The "CYP1B1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP1B1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets